- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.
Evercore ISI analyst Josh Schimmer is bullish on biotech.
A number of biotech-related stocks were down pre-market after announcing plans for public offerings.
The drug would be the first such treatment in Europe.
The labor market goes under inspection and Apple releases its earnings report.